HLB Therapeutics Market Cap

HLB Therapeutics has a market cap or net worth of 270.75 billion as of May 20, 2026. Its market cap has decreased by -58.55% in one year.

Market Cap

270.75B

Enterprise Value

288.91B

Revenue

69.56B

Ranking

n/a

PE Ratio

n/a

Stock Price

2,915.00

Market Cap Chart

Since March 26, 2010, HLB Therapeutics's market cap has increased from 105.80B to 270.75B, an increase of 155.89%. That is a compound annual growth rate of 5.99%.

Market Cap History

Date	Market Cap	% Change
May 20, 2026	270.75B	7.49%
Dec 30, 2025	251.87B	-73.05%
Dec 30, 2024	934.49B	182.02%
Dec 28, 2023	331.36B	-9.25%
Dec 29, 2022	365.14B	-3.64%
Dec 30, 2021	378.91B	-51.22%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
SillaJen	417.05B
Genomictree	343.24B
Helixmith	341.21B
Anterogen.Co.,Ltd.	330.20B
GC Cell	315.57B
BINEX	301.60B
NeoImmuneTech	247.66B
Bioneer	235.91B

Market Cap Rankings